27 research outputs found
Additional file 2 of Sorting and packaging of RNA into extracellular vesicles shape intracellular transcript levels
Additional file 2: Figure S2. (A) Plot of RNA-Seq reads from 3 EV and 3 cell samples that map to more than one genomic location. Reads mapping to rRNA are excluded. Individual values can be found in Additional file 17. (B) Hierarchical clustering of long RNA transcripts by abundance determined by RNA-Seq in 3 EV and 3 cell samples. Data are read counts transformed using the Variance Stabilizing Transformation, top 200 transcripts with the highest variance across samples are displayed. (C) RNA-Seq read coverage (top) and RT-PCR amplicons (bottom) of HNRNPA1 (D), ANP32B (E), RPL14 (F) and RPL41 (F) mRNA. (G) RNA-Seq read coverage (top) and RT-PCR amplicons (bottom) of lncRNA GAS5. NT = no template, no-RT = RNA without reverse transcriptase. Uncropped gel images can be found in Additional file 18
Additional file 11 of Sorting and packaging of RNA into extracellular vesicles shape intracellular transcript levels
Additional file 11. Fold changes, adjusted p-values and TPMs for genes in tumor-exposed, CD31-selected cells and their EVs
Additional file 16 of Sorting and packaging of RNA into extracellular vesicles shape intracellular transcript levels
Additional file 16. Fold changes, adjusted p-values and TPMs for genes in cells treated with GW4869 or not
Additional file 19 of Sorting and packaging of RNA into extracellular vesicles shape intracellular transcript levels
Table S1. PCR primer
Additional file 18 of Sorting and packaging of RNA into extracellular vesicles shape intracellular transcript levels
Additional file 18. Uncropped gels and blots
Additional file 7 of Sorting and packaging of RNA into extracellular vesicles shape intracellular transcript levels
Additional file 7. Fold changes, adjusted p-values and TPMs for genes in VEGF-treated cells and their EVs
Additional file 13 of Sorting and packaging of RNA into extracellular vesicles shape intracellular transcript levels
Additional file 13. Fold changes, adjusted p-values and TPMs for genes in CD31-selected EVs obtained from cells exposed to tumor cells or not
Additional file 12 of Sorting and packaging of RNA into extracellular vesicles shape intracellular transcript levels
Additional file 12. Fold changes, adjusted p-values and TPMs for genes in CD31-selected cells exposed to tumor cells or not
Additional file 6 of Sorting and packaging of RNA into extracellular vesicles shape intracellular transcript levels
Additional file 6: Figure S5. (A) mRNA and (B) lncRNA abundance from RNA-Seq in VEGF-treated cells and their EVs. TPM = transcripts per million. TPM values are averaged across 3 replicates. (C) Gene Ontology analysis of genes altered in cells by VEGF treatment. For each GO category the ten significant (FDR < 0.05) terms with the lowest p-values are displayed. BP = Biological Process, CC = Cellular Component, MF = Molecular Function. Individual values can be found in Additional file 17. (D) Volcano plot of log2 fold changes by RNA-Seq of mRNA and lncRNA genes (combined) in EVs derived from VEGF-treated cells vs. EVs derived from untreated cells. (E) Volcano plot of log2 fold changes by RNA-Seq of mRNA and lncRNA genes in VEGF-treated cells vs. untreated cells. All analyses were performed using 3 EV and 3 cell samples
Additional file 10 of Sorting and packaging of RNA into extracellular vesicles shape intracellular transcript levels
Additional file 10. Fold changes, adjusted p-values and TPMs for genes in CD31-selected cells and EVs